Evaluation of lymphadenopathy


Key articles

Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016 Dec 1;94(11):896-903.Full text  Abstract

Habermann TM, Steensma DP. Lymphadenopathy. Mayo Clin Proc. 2000 Jul;75(7):723-32. Abstract

Brown JR, Skarin AT. Clinical mimics of lymphoma. Oncologist. 2004;9(4):406-16.Full text  Abstract

Reference articles

1. Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016 Dec 1;94(11):896-903.Full text  Abstract

2. Kozuch P, Grossbard ML. Lymphadenopathy. In: Clinical hematology and oncology. New York, NY: Churchill Livingstone; 2003;213-20.

3. Habermann TM, Steensma DP. Lymphadenopathy. Mayo Clin Proc. 2000 Jul;75(7):723-32. Abstract

4. Fijten GH, Blijiham GH. Unexplained lymphadenopathy in family practice: an evaluation of the probability of malignancy causes and the effectiveness of physicians' workup. J Fam Pract. 1988 Oct;27(4):373-6. Abstract

5. Gurney KA, Cartwright RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J. 2002;3(2):95-104.Full text  Abstract

6. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011 Jul;124(7):588-97.Full text  Abstract

7. Pangalis GA, Vassilakopoulos TP, Boussiotis VA, et al. Clinical approach to lymphadenopathy. Semin Oncol. 1993 Dec;20(6):570-82. Abstract

8. Afzal W, Arab T, Ullah T, et al. Generalized lymphadenopathy as presenting feature of systemic lupus erythematosus: Case report and review of the literature. J Clin Med Res. 2016 Nov;8(11):819-823.Full text  Abstract

9. Brown JR, Skarin AT. Clinical mimics of lymphoma. Oncologist. 2004;9(4):406-16.Full text  Abstract

10. Herrada J, Cabanillas F, Rice L, et al. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998 Apr 15;128(8):657-62. Abstract

11. Norris AH, Krasinskas AM, Salhany KE, et al. Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy. Am J Med. 1996 Oct;101(4):401-5. Abstract

12. Moran CA, Suster S, Abbondanzo SL. Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity. Hum Pathol. 1997 Mar;28(3):332-8. Abstract

13. Kojima M, Nakamura S, Motoori T, et al. Progressive transformation of germinal centers: a clinicopathological study of 42 Japanese patients. Int J Surg Pathol. 2003 Apr;11(2):101-7. Abstract

14. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathologic entity. Arch Pathol. 1969 Jan;87(1):63-70. Abstract

15. Perry AM, Choi SM. Kikuchi-Fujimoto disease: A review. Arch Pathol Lab Med. 2018 Nov;142(11):1341-1346.Full text  Abstract

16. Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, et al. Non-Hodgkin lymphoma. BMJ. 2018 Aug 22;362:k3204.Full text  Abstract

17. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice: superior vena cava syndrome with malignant causes. N Engl J Med. 2007 May 3;356(18):1862-9. Abstract

18. Dumonceau JM, Deprez PH, Jenssen C, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline - updated January 2017. Endoscopy. 2017 Jul;49(7):695-714.Full text  Abstract

19. Ferrer R. Lymphadenopathy: differential diagnosis and evaluation. Am Fam Physician. 1998 Oct 15;58(6):1313-20.Full text  Abstract

20. Lee Y, Terry T, Lukes RJ. Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol. 1980;14(1):53-60. Abstract

21. Lister TA, Crowther D. Staging of Hodgkin's disease. Semin Oncol. 1990 Dec;17(6):696-703. Abstract

22. Morgenstern L. The Virchow-Troisier node: a historical note. Am J Surg. 1979 Nov;138(5):703. Abstract

23. Han F, Xu M, Xie T, et al. Efficacy of ultrasound-guided core needle biopsy in cervical lymphadenopathy: a retrospective study of 6,695 cases. Eur Radiol. 2018 May;28(5):1809-17. Abstract

24. Chau I, Kelleher MT, Cunningham D, et al. Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer. 2003 Feb 10;88(3):354-61.Full text  Abstract

25. Steel BL, Schwartz MR, Ramzy I. Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients: role, limitations and analysis of diagnostic pitfalls. Acta Cytol. 1995 Jan-Feb;39(1):76-81. Abstract

26. Ellison E, LaPuerta P, Martin SE. Supraclavicular masses: results of a series of 309 cases biopsied by fine needle aspiration. Head Neck. 1999 May;21(3):239-46. Abstract

27. Lamps LW, Scott MA. Cat-scratch disease: historic, clinical, and pathologic perspectives. Am J Clin Pathol. 2004 Jun;121(suppl 1):S71-80. Abstract

28. Selby CD, Marcus HS, Toghill PJ. Enlarged epitrochlear lymph nodes: an old physical sign revisited. J R Coll Physicians Lond. 1992 Apr;26(2):159-61. Abstract

29. Chandra S, Nehra M, Agarwal D, et al. Diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle biopsy in mediastinal lymphadenopathy: a systematic review and meta-analysis. Respir Care. 2012 Mar;57(3):384-91.Full text  Abstract

30. Pynnonen MA, Gillespie MB, Roman B, et al. Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngol Head Neck Surg. 2017 Sep;157(suppl 2):S1-30.Full text  Abstract

31. May B, Rossiter A, and Heyworth P. Core biopsy and FNA: a comparison of diagnostic yield in lymph nodes of different ultrasound determined malignant potential. Journal of Global Oncology. 2018 Sept;4(suppl 2):37s.

32. Scarsbrook AF, Barrington SF. PET-CT in the UK: current status and future directions. Clin Radiol. 2016 Jul;71(7):673-90. Abstract

33. Dudea SM, Lenghel M, Botar-Jid C, et al. Ultrasonography of superficial lymph nodes: benign vs. malignant. Med Ultrason. 2012 Dec;14(4):294-306.Full text  Abstract

34. Lin CK, Yu KL, Chang LY, et al. Differentiating malignant and benign lymph nodes using endobronchial ultrasound elastography. J Formos Med Assoc. 2019 Jan;118(1 pt 3):436-43.Full text  Abstract

35. Korrungruang P, Boonsarngsuk V. Diagnostic value of endobronchial ultrasound elastography for the differentiation of benign and malignant intrathoracic lymph nodes. Respirology. 2017 Jul;22(5):972-7. Abstract

36. Tawfik AM, Michael Bucher A, Vogl TJ. Dual-energy computed tomography applications for the evaluation of cervical lymphadenopathy. Neuroimaging Clin N Am. 2017 Aug;27(3):461-8. Abstract

37. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004 Oct 1;70(7):1279-87.Full text  Abstract

38. Linderholm M, Boman J, Juto P, et al. Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol. 1994 Jan;32(1):259-61.Full text  Abstract

39. Brigden ML, Au S, Thompson S, et al. Infectious mononucleosis in an outpatient population: diagnostic utility of 2 automated hematology analyzers and the sensitivity and specificity of Hoagland's criteria in heterophile-positive patients. Arch Pathol Lab Med. 1999 Oct;123(10):875-81. Abstract

40. Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004 Aug;42(8):3381-7.Full text  Abstract

41. Smellie WS, Forth J, Smart SR, et al. Best practice in primary care pathology: review 7. J Clin Pathol. 2007 May;60(5):458-65.Full text  Abstract

42. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: a predictive model for aggressive non-Hodgkin lymphoma. N Engl J Med. 1993 Sep 30;329(14):987-94.Full text  Abstract

43. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004 Sep 1;104(5):1258-65.Full text  Abstract

44. Stumpe KD, Urbinelli M, Steinert HC, et al. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma effectiveness and comparison with computed tomography. Eur J Nucl Med. 1998 Jul;25(7):721-8. Abstract

45. Isasi CR, Lu P, Blaufox MD. A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer. 2005 Sep 1;104(5):1066-74.Full text  Abstract

46. Tsukamoto N, Kojima M, Hasegawa M, et al. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Cancer. 2007 Aug 1;110(3):652-9.Full text  Abstract

47. Schoder H, Noy A, Gonen M, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2005 Jul 20;23(21):4643-51.Full text  Abstract

48. D'Addario G, Dieterle A, Torhorst J, et al. HIV testing and newly-diagnosed malignant lymphomas: the SAKK 96/90 registration study. Leuk Lymphoma. 2003 Jan;44(1):133-8. Abstract

49. Viswanatha DS, Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol. 2007 Dec;60(12):1378-83.Full text  Abstract

50. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with hematological malignancies. Br J Haematol. 2007 Mar;136(5):699-712. Abstract

51. Atkinson K, Austin DE, McElwain TJ, et al. Alcohol pain in Hodgkin's disease. Cancer. 1976 Feb;37(2):895-9.Full text  Abstract

52. Di Biagio E, Sanchez-Borges M, Desenne JJ, et al. Eosinophilia in Hodgkin's disease: a role for interleukin 5. Int Arch Allergy Immunol. 1996 Jul;110(3):244-51. Abstract

53. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease: international Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998 Nov 19;339(21):1506-14.Full text  Abstract

54. Varela-Lema L, Fernandez-Villar A, Ruano-Ravina A. Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration: a systematic review. Eur Respir J. 2009 May;33(5):1156-64.Full text  Abstract

55. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998 Jul 2;339(1):33-9. Abstract

56. Hammer SM. Clinical practice: management of newly diagnosed HIV infection. N Engl J Med. 2005 Oct 20;353(16):1702-10.Full text  Abstract

57. Helfand RF, Heath JL, Anderson LJ, et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis. 1997 Jan;175(1):195-9.Full text  Abstract

58. Centers of Disease Control and Prevention. Measles (rubeola): specimen collection, storage, and shipment. 5 June 2018 [internet publication].Full text

59. Allizond V, Costa C, Sidoti F, et al. Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: a comparative study. PLoS One. 2019;14(2):e0211945.Full text  Abstract

60. Golden M, Vikram HM. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005 Nov 1;72(9):1761-8.Full text  Abstract

61. National Institute for Health and Care Excellence. Tuberculosis. 12 September 2019 [internet publication].Full text

62. World Health Organization. WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection. Jun 2020 [internet publication].Full text

63. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):111-115.Full text  Abstract

64. Centers for Disease Control and Prevention. Tickborne diseases of the United States: a reference manual for healthcare providers, fifth edition. 2018 [internet publication].Full text

65. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44. Abstract

66. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007 Jun 5;146(11):797-808. Abstract

67. Klarlund M, Ostergaard M, Jensen KE, et al. Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. Ann Rheum Dis. 2000 Jul;59(7):521-8.Full text  Abstract

68. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153-65. Abstract

69. Kutok JL, Pinkus GS, Dorfman DM, et al. Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. Hum Pathol. 2001 Dec;32(12):1382-7. Abstract

70. Verma A, Stock W, Norohna S, et al. Progressive transformation of germinal centers: report of 2 cases and review of the literature. Acta Haematol. 2002;108(1):33-8. Abstract

71. Dimech W, Panagiotopoulos L, Francis B, et al. Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter. J Clin Microbiol. 2008 Jun;46(6):1955-60.Full text  Abstract

72. Wald A, Huang ML, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003 Nov 1;188(9):1345-51.Full text  Abstract

73. Reina J, Saurina J, Fernandez-Baca V, et al. Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples. Eur J Clin Microbiol Infect Dis. 1998 Jul;17(7):532-4. Abstract

74. Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol. 2005 Oct;106(4):845-56. Abstract

75. Guerry SL, Bauer HM, Klausner JD, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis. 2005 Jan 1;40(1):38-45.Full text  Abstract

76. Morse SA. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev. 1989 Apr;2(2):137-57.Full text  Abstract

77. Alfa M. The laboratory diagnosis of Haemophilus ducreyi. Can J Infect Dis Med Microbiol. 2005 Jan;16(1):31-4.Full text  Abstract

78. Lubwama SW, Plummer FA, Ndinya-Achola J, et al. Isolation and identification of Haemophilus ducreyi in a clinical laboratory. J Med Microbiol. 1986 Sep;22(2):175-8. Abstract

79. Totten PA, Kuypers JM, Chen CY, et al. Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for the detection of Haemophilus ducreyi. J Clin Microbiol. 2000 Jan;38(1):268-73.Full text  Abstract

80. Patterson K, Olsen B, Thomas C, et al. Development of a rapid immunodiagnostic test for Haemophilus ducreyi. J Clin Microbiol. 2002 Oct;40(10):3694-702.Full text  Abstract

81. Orle KA, Gates CA, Martin DH, et al. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol. 1996 Jan;34(1):49-54.Full text  Abstract

82. Morse SA, Trees DL, Htun Y, et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis. 1997 Mar;175(3):583-9. Abstract

83. Mackay IM, Harnett G, Jeoffreys N, et al. Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clin Infect Dis. 2006 May 15;42(10):1431-8.Full text  Abstract

84. Chui L, Albritton W, Paster B, et al. Development of the polymerase chain reaction for diagnosis of chancroid. J Clin Microbiol. 1993 Mar;31(3):659-64.Full text  Abstract

85. Elkins C, Yi K, Olsen B, et al. Development of a serological test for Haemophilus ducreyi for seroprevalence studies. J Clin Microbiol. 2000 Apr;38(4):1520-6.Full text  Abstract

86. Knapp JS, Back AF, Babst AF, et al. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob Agents Chemother. 1993 Jul;37(7):1552-5.Full text  Abstract

87. Roy-Leon JE, Lauzon WD, Toye B, et al. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. J Antimicrob Chemother. 2005 Sep;56(3):552-8.Full text  Abstract

88. Vijayachari P, Sugunan AP, Shriram AN. Leptospirosis: an emerging global public health problem. J Biosci. 2008 Nov;33(4):557-69. Abstract

89. Chawalparit O, Charoensak A, Niwattayakul K, et al. Radiographic chest findings and clinical correlations in leptospirosis. J Med Assoc Thai. 2007 May;90(5):918-24. Abstract

90. Blum T, Kollmeier J, Ott S, et al. Computed tomography for diagnosis and grading of dust-induced occupational lung disease. Curr Opin Pulm Med. 2008 Mar;14(2):135-40. Abstract

Use of this content is subject to our disclaimer